The global collaboration expands to Australia, enabling Asia-Pacific organisations to meet compliance, data sovereignty and low-latency inference requirements
Nanyang Biologics aims to accelerate drug discovery through artificial intelligence (AI) and boost Singapore as a leading hub for AI-driven life sciences, healthcare and biomedical research
Supporting the metropolitan city to help organizations further capitalize on GBA’s and global business opportunities leveraging digital ecosystems and cloud/network connectivity on Platform Equinix®
By visiting the Press Resource Center, you acknowledge assets featured on this page may be used for
publication as long as proper credit is given to Equinix as the source ("Source: Equinix").